Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
350 participants
OBSERVATIONAL
2013-06-30
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes
NCT06630650
Brain Involvement in Dystrophinopathies Part 1
NCT04583917
The Neuroimage Study of the Neuromuscular Disorders.
NCT05048862
Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database
NCT04613089
Impact of Sensory, Motor and Vestibular Deficit on the Postural Stability of CMT Patients
NCT06425952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Natural History
Assessment of natural history in IBM and CCFDN
Natural History
Assessment of natural history in IBM and CCFDN
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Natural History
Assessment of natural history in IBM and CCFDN
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maggie Walter
Professor, MD, MA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maggie C Walter, MD, MA
Role: STUDY_CHAIR
Friedrich-Baur-Institute, Dept. of Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Friedrich-Baur-Institut, Ludwig-Maximilians-University of Munich
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCFDN-IBM-2013
Identifier Type: OTHER
Identifier Source: secondary_id
CCFDN-IBM-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.